chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left side of face became numb; Left side of face became tingly; Left side of face became hot; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Mar2021 at 20:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not report any other health issues. The patient had no known allergies to medications, food or other products. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unspecified date in Mar2021, the patient reported that the left side of the face became tingly, hot and numb. The events did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event left side of the face became tingly, hot and numb. The clinical outcome of the event left side of the face became tingly, hot and numb was resolved with sequelae on an unspecified date in 2021.   No follow-up attempts are needed; information about lot number cannot be obtained.
15 minutes after IM injection of Gardasil in right arm. Patient developed hives on her neck right side continued to move up on face. 20 minutes post injection rash and then itching over neck, face and back. Benadryl used IM. Vital signs remained stable.
DIFFERNCE OF LOT # TO MANUFACTURER:  Told got Janssen but lot # is Moderna.  He got his vaccine, had no reaction other than his arm hurting.  Then on 4/10/21 in the afternoon he started having ringing in the ears.  He said that it is pretty bad, and is on and off and bad when it occurs.  He has it more days than not and has never had this condition before.  He did a telephone APT and informed him of his issue and is aware.  He told him to wait and see if it goes away.
Patient received first dose of the COVID-19 Pfizer vaccine. I was alerted by the patient's friend that he fainted. I went to check on the patient and he was unconscious. He quickly regained consciousness and asked for water. I proved him with water,  moments later he began to vomit. I continued to monitor the patient and after about 10-15 minutes he began to feel a lot better. He call someone to come and pick him up and take him home. I advised the patient to remain seated for another 10-15 minutes, and he did so. He began to feel a lot better and then went home.
Gradually worsening chest pain throughout the day yesterday and continuing pain today. Resting heart rate up to 187.
Fever, aches, headache, fatigue on first night after vaccine (day 1) which continued into next day. Symptoms eased a bit. On Thursday (day 4) serious fatigue returned and intestinal distress began.  Severe diahrrea began Friday (day 5) morning and lasted until Monday (day 8) before easing. Provided stool sample to clinic on day 7 and on day 8 received diagnosis of giardia. No treatment and symptoms entirely by Tuesday (day 9).
This case was reported by a consumer (also the subject) and described the occurrence of anaphylactic reaction in a 37-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline) and FLULAVAL. A physician or other health care professional has not verified this report. Concurrent medical conditions included latex allergy and possible allergy to penicillin. Concurrent medications included SYNTHROID and Oral contraceptive. On 12 January 2012 at 14:00 the subject received a dose of BOOSTRIX (unknown route, left arm) and FLULAVAL (unknown route, right arm). On 13 January 2012, approximately 15 minutes after vaccination with BOOSTRIX and FLULAVAL, the subject experienced anaphylactic reaction, swollen tongue and swollen throat. This case was assessed as medically serious by GSK. The subject was treated in an emergency room with Epinephrine, prednisone and BENADRYL. At the time of reporting the events were improved.
2 days later, severe headache, 3 days later lip drooping, 4 days later diagnosed with Bell's Palsy.
1/25 -Pain back of neck, shoulder, under left arm-took 2-motrin in am - pain intense-took 2-500mg tylenol in PM-spoke w/doctor at 6:30 pm to make sure he wasn't having a heart attack. Pain was so bad went to ER ran tests to make sure it was not heart related-most likely vaccination! 1/26-pain all night applied moist heat, applied biofreeze-nothing would touch the pain. 1/26-Called doctor-suggested he see his son doctor/Chiropractor at 4pm-felt okay until he got in car and pain was back. 1/27-Pain left arm down to fingers-not sleeping -doctor suggested seeing chiropractor again at 9am today-still has a lot of pain. Saw doctor who ordered Tramadol twice a day as needed.
Tinnitus.  Significant and constant ringing in ears. I previously suffered from occasional tinnitus but not this "loud" and not constantly.
Dose administered past 30 days in refrigerator; Received dose from vial that was more than 30 days refrigerated; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered past 30 days in refrigerator) and PRODUCT STORAGE ERROR (Received dose from vial that was more than 30 days refrigerated) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered past 30 days in refrigerator) and PRODUCT STORAGE ERROR (Received dose from vial that was more than 30 days refrigerated). On 03-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered past 30 days in refrigerator) and PRODUCT STORAGE ERROR (Received dose from vial that was more than 30 days refrigerated) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient received the Moderna COVID-19 vaccine on 03-Oct-2021 from a vial that was past the 30-day beyond use date in the refrigerator. It was reported that vial was moved to refrigerator on 31-Aug-2021 and the 30-day use by date was 30-Sep-2021.  No concomitant medication was reported. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Oct-2021: Follow up received contains no new information.
felt "weird" about 15 min after, began having diaphoresis and tremors. Given 25 Benadryl po nand 20 mg famotidine po, BP 190/80 other vitals remained wnl, about 15 min after PO meds began feeling s/s subside and over next hour BP decreased to 160's/70's. Monitored and all s/s resolved
p/vax pt devel fever, some small amount of pox which was itchy;@ time of report, the pox had scabbed over;pt sought unspecified medical attention;
1st RXN couldn't move arm few days. Fever x 4-5 days. Sick on 5th (maybe 4th) day & swelled up twice site with redness - entire arm. Next to urgent care & diagnosed with allergic RXN. Areas of arm appeared burned. Tx - steroids.
Extreme heart palpitations for 2.5 weeks (150-180 bpm); high blood pressure readings 134 - 180 mm Hg several times; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (Pfizer-Biontech Covid-19 vaccine), dose 1 via an unspecified route of administration, administered in Arm Right on an unspecified date (Batch/Lot Number: EW0153) as dose 1 single for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took bactrim and experienced drug allergy. On 10Apr2021 11:00, the patient experienced extreme heart palpitations for 2.5 weeks (150-180 bpm), high blood pressure readings 134 - 180 mm Hg several times, vision disturbances such as floaters, light sensitivity, trouble focusing, and spots. The patient received IV fluids, EKG (unknown result as reported), anti-anxiety medication as treatment. The events required Doctor or other healthcare professional office/clinic visit and visit to the Emergency room/ department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19 - Abbott Rapid Test with negative result on 16Apr2021 (Nasal Swab). The outcome of the events was not recovered.
On January 8, 2021, I felt bumps on the right side of my back.  They appeared to be shingles.  After discussing my symptoms with Dr. , he prescribed a course of valacyclovir.  I took this for 1 week.  The blisters, redness, and pain in my back/torso improved over time.  They lesions are now completely gone.
Patient developed fever, chills, and whole body aches. He went to the ER and they ran tests and everything came back clear.  They did do a Covid 19 test and results are pending
Suspected Localized Cellulitis Of Upper Left Extremity 14cm X 14.5cm - Patient placed on Augmentin
After I had my vaccine after 8 hours I have hair falling out; which I seen my doctor for it
Patient received GARDASIL on 5/15/08. Patient developed intermittent episodes of dizziness starting 5/22/08 continuing daily until 6/12/08. Episodes subsided hen and have not reoccurred. This information reported on 7/17/08 by mother to our office.
Patient reports acute feelings of being flush in the face, and weak, as well as profusely sweating and increased heart rate. All symptoms resolved in about 5 minutes.
Pt presented to ER on 9/26/09 (Saturday) with erythema, swelling involving approximately 1/2 of upper arm in the arm that vaccine was administered. ER diagnosed cellulitis and treated with antibiotics. However, pt was afebrile and had 80-90% resolution of symptoms as of9/28/09. My medical opinion is that pt had local reaction, no true cellulitis.
Pt called in at 4:40pm roughly 4 hours after vaccine. Pt felt numbness/tingling sensation immediately after vaccine was administered. Pt stated that the symptom got better over time. No other symptoms present. Pt education on common side effects, adverse reactions, when to seek medical attention, and to follow up with PCP.
Arm redness and swelling from shoulder down to elbow. Patient advised to use cold compress, give oral Claritin and local anti-itch cream.
Headache, fever, chills, swollen lymph nodes, retaining water, upper back pain.
A non-serious report of administration of expired FluMist has been received from a nurse concerning a seven-year-old male.  Neither medical history nor concomitant medications were provided.  The patient received FluMist on 14-Mar-2008.  The FluMist had expired on 10-Mar-2008.  The reporter stated that she received 100 doses of FluMist from the Vaccines For Children Program on 22-Feb-2008 and the vaccine expired on 10-Mar-2008.  The clinic did not realize the expiration date on the product and continued to give it from 11-Mar-2008 to 17-Mar-2008 to 26 patients.  The patient had no adverse events at the time the report was received, neither as of 18-Apr-2008 when the office was contacted for follow-up information.  The event has resolved.  It was not reported whether or not FluMist was re-administered.  The reporter provided no causality assessment for the event.  The reporting source of this case is spontaneous, thus the sponsor's comment is not applicable.  Follow-up information received 18-Apr-2008 and incorporated into the narrative: no adverse event occurred.  This case is linked to the following 25 other cases reported from the same reporter: MEDI-0006660; MEDI-0006661; MEDI-0006662; MEDI-0006663; MEDI-0006664; MEDI-0006665; MEDI-0006666; MEDI-0006667; MEDI-0006668; MEDI-0006669; MEDI-0006670; MEDI-0006671; MEDI-0006672; MEDI-0006673; MEDI-0006674; MEDI-0006675; MEDI-0006676; MEDI-0006677; MEDI-0006659; MEDI-0006679; MEDI-0006680; MEDI-0006681; MEDI-0006682; MEDI-0006683; MEDI-0006684.
Patient explained that at doses 1, 2, and 3 she experienced chest tightness and pain 4 hrs after the vaccine was administered. The symptoms lasted 1 wk and resolved on its own.
P/immun pt slept & was extremely lethargic for next 24 hrs; did not want to eat or drink; t101; moist cough & sl runny nose; MD asked to watch closely for next 24 hrs; also exp periods of paleness;
Lichen planus; exacerbation of oral lichenoid mucositis; This is a literature report.  A 65-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "carcinoma-in-situ of the left lateral border of tongue" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Vitamin a for lichenoid, notes: 0.025% gel, topical; Clobetasol for lichenoid, notes: 0.05% gel twice daily. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunisation. The following information was reported: LICHEN PLANUS (medically significant), 1 week after the suspect product(s) administration, outcome "recovered"; ORAL LICHENOID REACTION (medically significant), 1 week after the suspect product(s) administration, outcome "recovered", described as "exacerbation of oral lichenoid mucositis". Therapeutic measures were taken as a result of lichen planus, oral lichenoid reaction. Clinical course: Female with a history of carcinoma-in-situ of the left lateral border of tongue, had ongoing follow-up in the oral medicine clinic for lichenoid changes. She had been originally managed with topical vitamin A 0.025% gel and clobetasol 0.05% gel twice daily with excellent response. One week after receiving the second dose of the Pfizer-BioNTech vaccine, she developed sensitivity and ulceration of the buccal mucosa and tongue. Lichenoid striations and ulceration at Buccal mucosa and tongue observed. Oral findings resolved after 4 weeks of the original topical therapy at an increased frequency to 4 times daily.; Sender's Comments: Based on the available information in the case, an association between the reported events and The suspected drug cannot be ruled out.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-PV202200111251 Same article/ drug/event and different patient:;
bad headache; muscle pain in her jaw; Jaw pain; he went to withheld and got the 3rd pfizer vaccine; This is a spontaneous report from a contactable consumer. A 68-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 3 via an unspecified route of administration on 23Aug2021 (at the age of 68-years-old) (Batch/Lot Number: FD8448) as dose 3, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient previously took first dose of BNT162B2 (at the age of 68-years-old) (lot number: EL3246, vaccine location: Right arm) on 07Jan2021 and second dose of BNT162B2 (at the age of 68-years-old) (lot number: EL3246) on 26Jan2021 for covid-19 immunisation. Patient previously took Flu Shot 25 years ago reported to CDC. The patient experienced bad headache and muscle pain in her jaw on 24Aug2021. The patient was administered with 3rd dose of covid-19 vaccine and exposed to off label scenario. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received treatment for the event bad headache. The outcome of the event bad headache and muscle pain in her jaw and jaw pain was not recovered. The outcome of all the other events was unknown.
? Sinus Problem     bilat ear pain/pressure, headache, cough, drainage, nasal congestion
Ten minutes after receiving this vaccination, I began to feel intense, unnatural perspiration, dizziness, nausea, and blurry vision. Additionally, my heart rate increased, and I turned pale. These symptoms lasted for approximately ten to fifteen minutes. I have never experienced this after blood work or dental work, nor have I ever experienced this after receiving any other vaccination.
Presents to emergency department today (10/11/21) with left facial droop and left facial numbness and tingling.  Patient states around noon this afternoon friend of his at work told him that his left face was drooping.  He states that he had not noticed it prior to this point.  He reports around 3:00 this afternoon he noticed some numbness and tingling to the left side of his face.  He reports then he decided come into the emergency department today.  He states that he was essentially last known well last night around 10 PM last night when he went to bed however when he woke up this morning he did not notice any left facial droop this morning when he was getting dressed.  On arrival stroke alert was called.  Patient was emergently taken to CAT scan.  Patient was evaluated by the stroke neurologist.  He denies any previous history of TIA or stroke in the past.  He denies any focal weakness.  He denies any speech difficulty, slurred speech, dysarthria or aphasia.  He denies any double vision or blurry vision.  Denies any headache.  He denies having any chest pain or shortness of breath.  He does report a remote history of hypertension however does not take any blood pressure medications.  He denies any chest pain or shortness of breath.  He denies any other complaints today.
Patient was accidently administered an unconstituted vial of Pfizer - Covid-19 Vaccine.  Patient left premises prior to waiting 15 minute observation period. Patient was contacted via phone number and asked to return to the clinic. They were informed of the mistake and symptoms to look out for, patient was observed for 1hr after their return to clinic.
3rd Moderna dose was 11/09/2021, I started having a bubbling in tummy. 11/23/2021, Also had an irritating nagging cough, non productive. Tried to resolve it on my own. Doctor put me on Cough Suppressant, Antibiotics. Did a telehealth and he thought maybe acid reflux so he put me on Prilosec. He doubled my dose. Cough has resolved. Everything felt in flames and pain in my leg. It is getting better as of today. I was going to get my 4th booster but it seems this happened right after the shot. I'm having a colonoscopy in June.
Around November 25th, I started to feel like I had a really bad cold. I had a temperature, felt congested, was wheezing and I was coughing a lot. I went to the doctor and they diagnosed me with having Sinusitis, Bronchitis and RSV. I was given 5 rounds of steroids and antibiotics. As of today, I am feeling okay. I still have a lingering cough.
This case was reported by a nurse via call center representative and described the occurrence of rash in a 52-year-old female patient who received SHINGRIX (batch number TP5E5, expiry date 15th November 2020) for prophylaxis. On 3rd July 2018, the patient received the 1st dose of SHINGRIX .5 ml. In July 2018, 2 days after receiving SHINGRIX, the patient experienced rash. On an unknown date, the outcome of the rash was recovered/resolved. The reporter considered the rash to be unrelated to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on the left arm. The healthcare professional reported that,  the patient experienced a rash under the arm (left arm pit area). It was stated that, the reaction started a few days after the vaccination date which lasted for 3 to 4 weeks. The patient also shaved after receiving the vaccine. The healthcare professional would like to know if this was a common reaction and if the patient should receive the 2nd dose. This was escalated to an MED for recommendations.
Per patients follow up visit, reported via physician hardness, erythema, swelling and discomfort over left deltoid area after pneumonia injection lasting several days. Spontaneously got better, now fully recovered.
FEELS LIKE NOT GETTING ENOUGH OXYGEN; CHEST HEAVINESS; LETHARGIC; MIGRAINES; BODY ACHES; NO ENERGY; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included tested positive for Covid-19, and concurrent conditions included extreme fatigue. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total dose administered on MAR-2021 (approximately 2 weeks prior to the pause) for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAR-2021 (after receiving vaccination), the patient developed migraines, no energy, headache, body aches, lethargic and a chest heaviness that felt like she was "not getting enough oxygen." She mentioned that she has seen by her primary care providers (PCP)/ health case professional (HCP) for the symptoms for evaluation and treatment. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the lethargic, migraines, headache, body aches, chest heaviness, no energy and feels like not getting enough oxygen was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0;20210502472-Covid-19 vaccine.Ad 26.Cov2.S-Feels like not getting enough oxygen. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Pt called at approx 4:15pm on 5/29/19. Left vm stating she had redness and swelling where she received her immunizations the previous day and that she was running a fever. Wanted to know if this was normal. I spoke w/ her at approx 5:15pm and let her know this is normal, especially with the Men B vaccine. Advised her to go to the ER if she developed s/sx of allergic reaction (reviewed w/ her). Advised her that she could alternate Tylenol/Motrin for the discomfort and fever and that she could apply a warm compress to the site to help alleviate swelling.
Flu like symptoms- fever, headache, body ache, nausea for 3 days.
Pt recvd 1st dose of Hep B vax 5OCT91 & w/in 6 hrs of receiving vax pt exp severe nausea, explosive vomiting, & fatigue; sx lasted 2 1/2 days;
9/13/2012 The next morning huge lump goose egg size, red and itched like crazy, arm pit hurt. There is a bruise there now, no lump. 48 hours after shot, had a severe case of chills, but then the next day felt fine.
1 day later with large local reaction of edema, warmth and pain with mild itching.